FIGURE

Fig. 2

ID

ZDB-FIG-250207-57

Publication

Della Vecchia et al., 2025 - Dapagliflozin ameliorates Lafora disease phenotype in a zebrafish model

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

LFP recordings in WT (n = 14), epm2a^−/− (n = 14) and DAPA-treated epm2a^−/− (n = 14) animals. Violin plots of the duration (A) and power (B) of the seizure-like events detected in all epm2a^−/− (n = 14) and DAPA-treated epm2a^−/− (n = 14) fish. The red line represents the mean, and the black lines represent SEM. Statistical analysis was performed using the Kruskal-Wallis test. Dunn’s test was used to perform post-hoc analysis for multiple comparisons after the Kruskal-Wallis test. (****p ≤ 0.0001; ***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	epm2a^{zf3794/zf3794} (AB)
Condition:	chemical treatment by environment: dapagliflozin
Observed In:	forebrain neuronal action potential
Stage:	Day 5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.